ResearcherOregon Health & Science UniversityNo recent work listed

Robert M. Strongin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3777-8492; OpenAlex author ID A5054319532. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper

Papers 2

Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. Last author DOI 10.1016/j.ymeth.2019.06.008 ↗
Far-Red and Near-Infrared Seminaphthofluorophores for Targeted Pancreatic Cancer Imaging. Last author DOI 10.1021/acsomega.6b00403 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Summer L. Gibbs · 2 shared papers, 2017–2019 · strength 0.18
- Paper Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. DOI 10.1016/j.ymeth.2019.06.008 ↗
- Paper Far-Red and Near-Infrared Seminaphthofluorophores for Targeted Pancreatic Cancer Imaging. DOI 10.1021/acsomega.6b00403 ↗
Lei G. Wang · 2 shared papers, 2017–2019 · strength 0.18
- Paper Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. DOI 10.1016/j.ymeth.2019.06.008 ↗
- Paper Far-Red and Near-Infrared Seminaphthofluorophores for Targeted Pancreatic Cancer Imaging. DOI 10.1021/acsomega.6b00403 ↗
Ian Munhenzva · 1 shared paper, 2019 · strength 0.11
- Paper Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity. DOI 10.1016/j.ymeth.2019.06.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.